Few topics in sport and fitness carry as much controversy, mythology, and misunderstanding as anabolic-androgenic steroid (AAS) use in bodybuilding. Condemned in mainstream discourse yet quietly ubiquitous in competitive physique sport, steroids occupy a paradoxical space: simultaneously vilified and systematically employed by a significant portion of the bodybuilding population.
Understanding why bodybuilders use steroids requires moving past moral judgements and into the underlying physiology. The honest answer is straightforward — these compounds work. They accelerate muscle growth, speed recovery, enhance strength, and allow athletes to train with a volume and frequency that is physiologically impossible for a natural trainee. This article explores the biological mechanisms behind these effects, examines specific compounds commonly used, and contextualises why, from a performance standpoint, AAS use has become entrenched in competitive bodybuilding culture.
The Androgen Receptor: Where It All Begins
Anabolic-androgenic steroids are synthetic derivatives of testosterone, the primary male sex hormone. Their effects are mediated primarily through the androgen receptor (AR), a ligand-activated transcription factor expressed in skeletal muscle, bone, the central nervous system, and many other tissues.
When an AAS molecule binds to the AR, the receptor undergoes a conformational change, translocates to the cell nucleus, and binds to androgen response elements (AREs) on DNA. This directly upregulates the transcription of genes involved in protein synthesis — particularly those encoding muscle structural proteins like myosin heavy chain and actin. The net effect is a shift in the muscle cell’s net protein balance from catabolic toward anabolic: more protein is built than is broken down.
Critically, this effect is dose-dependent and supra-physiological. Endogenous testosterone in adult males typically sits between 300–1,000 ng/dL. Bodybuilders using AAS often sustain serum androgen levels many times this range, driving protein synthesis rates that cannot be achieved through training and nutrition alone. A landmark study by Bhasin et al. (1996) demonstrated that supraphysiological testosterone administration (600 mg/week) produced significant gains in lean mass even in the absence of exercise, and augmented exercise-induced gains substantially compared to placebo.
Muscle Hypertrophy: The Core Mechanism
Skeletal muscle hypertrophy occurs when mechanical stress and anabolic signalling exceed muscle protein breakdown over time. AAS influence this process through multiple pathways:
Enhanced Protein Synthesis
AAS directly stimulate ribosomal biogenesis and the mTORC1 pathway — the master regulator of anabolic signalling in muscle. Testosterone activates mTORC1 independently of the PI3K/Akt pathway, providing a complementary anabolic stimulus on top of the one triggered by resistance training itself.
Satellite Cell Activation
Muscle satellite cells are resident stem cells essential for muscle repair and growth. AAS — particularly testosterone and its derivatives — increase satellite cell proliferation and fusion into existing muscle fibres. This is significant because satellite cells also donate nuclei to muscle fibres, increasing the myonuclear domain and the fibre’s capacity to support a larger volume of contractile protein. Some research suggests these additional myonuclei persist long after steroid cessation, which may partially explain the contested concept of “muscle memory.”
Anti-Glucocorticoid Effects
Cortisol and other glucocorticoids are catabolic hormones released in response to training stress. They promote protein breakdown and impair recovery. AAS compete with glucocorticoids at the receptor level, blunting their catabolic effect. This is particularly relevant during high-volume training phases where cortisol output is substantial.
IGF-1 Upregulation
AAS increase hepatic and local muscular production of insulin-like growth factor 1 (IGF-1), a potent anabolic peptide that stimulates muscle protein synthesis and satellite cell activity through its own receptor pathway.
Recovery: Training More, Recovering Faster
One of the most underappreciated advantages conferred by AAS in bodybuilding is not the direct anabolic effect per se, but the dramatic improvement in recovery capacity. Natural athletes are constrained by how quickly their muscles, connective tissues, and nervous systems can recover between sessions. AAS fundamentally alter this constraint.
By accelerating muscle protein resynthesis, suppressing post-exercise cortisol activity, and enhancing glycogen replenishment (partly through IGF-1-mediated glucose uptake), AAS allow bodybuilders to train with much higher frequency and volume. Where a natural trainee may optimally train a muscle group once or twice per week, an enhanced athlete may train each muscle group three or more times weekly with high volume — accumulating a training stimulus that a natural physiology could not sustain or recover from.
This is a key reason why the training protocols of elite professional bodybuilders are not transferable to natural athletes. The volume is not the cause of the result — it is only productive because of the pharmacological support underpinning the recovery.
Specific Compounds and Their Roles
Different AAS compounds are selected for their specific pharmacological profiles. Experienced bodybuilders typically use multiple compounds simultaneously — a practice called “stacking” — to exploit the distinct mechanisms of each.
Testosterone (Various Esters)
The foundational compound. Testosterone enanthate and cypionate are long-acting esters used as a base in most cycles, providing stable androgen levels. Testosterone propionate is a short-ester variant used when finer hormonal control is desired, particularly pre-competition. Testosterone provides both anabolic and androgenic effects and supports libido, mood, and erythropoiesis during suppression of the hypothalamic-pituitary-gonadal (HPG) axis.
Nandrolone (Deca-Durabolin)
A 19-nor (19-nortestosterone) derivative with a high anabolic-to-androgenic ratio. Nandrolone is prized for promoting lean mass gains with less androgenic side-effect burden than testosterone. It also has a collagen-stimulating effect, which bodybuilders associate with joint support during heavy training — though its reduced conversion to dihydrotestosterone (DHT) makes it gentler on the prostate and scalp. A significant drawback is its potent suppression of endogenous testosterone and its interference with the HPTA, which can be prolonged.
Trenbolone (Acetate / Enanthate)
Perhaps the most potent compound used in bodybuilding. Trenbolone does not aromatise to oestrogen and has an extraordinarily high binding affinity for the androgen receptor — approximately five times that of testosterone. It dramatically increases nitrogen retention, promotes fat oxidation, and causes significant increases in IGF-1. Trenbolone is known for producing a hard, dense, vascular musculature particularly valued pre-contest. Its side effect profile is substantial, however, including cardiovascular strain, neurological effects (anxiety, aggression, night sweats), and severe HPTA suppression.
Boldenone (Equipoise)
Originally a veterinary compound, boldenone is valued for its ability to increase erythropoietin (EPO) secretion, leading to elevated red blood cell mass, improved oxygen delivery, and enhanced muscular endurance. It aromatises at roughly half the rate of testosterone and is generally considered a milder compound, often used in longer cycles during “building” phases.
Stanozolol (Winstrol)
A DHT-derived compound with no oestrogenic activity, stanozolol is used almost exclusively in pre-competition phases. It does not contribute meaningfully to mass gain but promotes a dry, hard appearance by reducing water retention. It has notable SHBG (sex hormone-binding globulin) suppression, which increases the free fraction of other androgens in the stack.
Oxandrolone (Anavar)
Anavar is a mild oral compound with a high anabolic-to-androgenic ratio. It is notable for preserving lean mass during caloric restriction — making it popular in cutting phases. Its hepatotoxicity is lower than other oral 17-alpha-alkylated compounds, though not absent. It is also one of the few AAS studied in clinical populations including women, due to its relatively low androgenic activity.
The Role of Oestrogen Management
Testosterone and some other AAS aromatise — meaning they are converted by the enzyme aromatase to oestradiol (oestrogen). While oestrogen serves important functions even in male physiology (bone density, cardiovascular health, libido), supraphysiological levels cause gynaecomastia (breast tissue development), water retention, and mood disturbances.
Bodybuilders manage this through aromatase inhibitors (AIs) such as anastrozole or letrozole, or selective oestrogen receptor modulators (SERMs) like tamoxifen. The balance between androgen and oestrogen is carefully managed, since both too much and too little oestrogen causes problems — overly aggressive AI use can negatively impact lipid profiles, joint health, and mood.
Health Risks: The Pharmacological Trade-Off
No scientifically honest account of AAS use can omit the associated health risks, which are real, dose-dependent, and in some cases irreversible.
The most serious concern is cardiovascular toxicity. AAS — particularly oral 17-alpha-alkylated compounds and trenbolone — cause adverse shifts in lipid profiles (suppressed HDL, elevated LDL), left ventricular hypertrophy, increased haematocrit, and arterial stiffness. Long-term use is associated with significantly elevated risk of myocardial infarction, stroke, and sudden cardiac death.
HPTA suppression is universal with AAS use. Exogenous androgens suppress GnRH, LH, and FSH, shutting down endogenous testosterone production and spermatogenesis. Recovery of the axis after cessation can take months and may be incomplete with prolonged or heavy use. Post-Cycle Therapy (PCT) protocols using SERMs (clomiphene, tamoxifen) are standard practice to stimulate HPG axis recovery.
Other risks include hepatotoxicity (particularly with oral compounds), mood dysregulation, dermatological effects (acne, androgenic alopecia in genetically predisposed individuals), and tendon injury risk (muscle strength can outpace connective tissue adaptation).
Why the Culture Persists
Despite these risks, AAS use in competitive bodybuilding is essentially universal at elite levels, and prevalent well into recreational and amateur levels. The reasons are structural as much as pharmacological.
Modern competitive bodybuilding — particularly the open professional divisions — rewards a level of muscularity that is physiologically unachievable without pharmacological assistance. The sport’s aesthetic standards evolved in the context of steroid availability from the 1960s onward. Competitors who choose not to use AAS cannot reach the podium in most open divisions, creating a coercive dynamic: compete naturally and lose, or use AAS and compete on equal terms with peers.
At the recreational level, social media has compressed the feedback loop between aspiration and action. Physiques that would have required years of context to understand as pharmacologically assisted are now displayed prominently, creating unrealistic benchmarks that drive some individuals toward AAS earlier and at higher doses than historical norms.
Conclusion
Anabolic-androgenic steroids are used in bodybuilding because they profoundly and demonstrably work — through direct stimulation of androgen receptors, upregulation of protein synthesis pathways, satellite cell activation, anti-catabolic effects, and recovery enhancement. Specific compounds are selected for their distinct pharmacological profiles and combined strategically to maximise muscle hypertrophy, body composition, and training capacity.
This is not an endorsement of AAS use. The cardiovascular, endocrine, and psychological risks are significant and should be understood clearly by anyone considering these compounds. But a scientific understanding of why these substances are used — and how they work — is essential for honest conversations about bodybuilding, drug policy in sport, and the physiology of human performance.